世界の酸化ストレスアッセイ市場(~2025年):製品別(消耗品、機器、キット、サービス)、テストタイプ別(間接、核酸、グルタチオン、ROS)、技術別(ELISA、クロマトグラフィー)、疾患別(CVD、腫瘍)、エンドユーザー別(製薬、バイオテクノロジー)

■ 英語タイトル:Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, nucleic acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End Users (Pharma & Biotech) - Global Forecasts to 2025

調査会社MarketsandMarkets社が発行したリサーチレポート(データ管理コード:BT3416)■ 発行会社/調査会社:MarketsandMarkets
■ 商品コード:BT3416
■ 発行日:2029年4月23日
■ 調査対象地域:グローバル
■ 産業分野:バイオ
■ ページ数:181
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥722,700見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥970,900見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,189,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の酸化ストレスアッセイ市場(~2025年):製品別(消耗品、機器、キット、サービス)、テストタイプ別(間接、核酸、グルタチオン、ROS)、技術別(ELISA、クロマトグラフィー)、疾患別(CVD、腫瘍)、エンドユーザー別(製薬、バイオテクノロジー)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

マーケッツアンドマーケッツ社は、世界の酸化ストレスアッセイ市場規模が2020年836百万ドルから2025年1,326百万ドルまで、年平均9.7%成長すると予測しています。本調査レポートでは、酸化ストレスアッセイの世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(消耗品、機器、サービス)分析、技術別(ELISA、フローサイトメトリー、クロマトグラフィー、顕微鏡、ハイコンテントスクリーニング)分析、テストタイプ別(間接アッセイ、抗酸化能アッセイ、酵素ベースアッセイ、活性酸素種ベースアッセイ)分析、疾患別(心血管疾患、癌、糖尿病、呼吸器疾患、その他)分析、地域別分析、競争状況、企業情報などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の酸化ストレスアッセイ市場規模:製品・サービス別(消耗品、機器、サービス)
・世界の酸化ストレスアッセイ市場規模:技術別(ELISA、フローサイトメトリー、クロマトグラフィー、顕微鏡、ハイコンテントスクリーニング)
・世界の酸化ストレスアッセイ市場規模:テストタイプ別(間接アッセイ、抗酸化能アッセイ、酵素ベースアッセイ、活性酸素種ベースアッセイ)
・世界の酸化ストレスアッセイ市場規模:疾患別(心血管疾患、癌、糖尿病、呼吸器疾患、その他)
・世界の酸化ストレスアッセイ市場規模:地域別
・競争状況
・企業情報

“The oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%.”
Growth in the oxidative stress assay market can be attributed to growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of this market include technological advancements like HCS for drug discovery, increasing R&D expenditure in biotechnology and pharmaceutical industries, and government support for pharmaceutical and biotechnology industries. On the other hand, the high cost of instruments and shortage of trained and qualified personnel are the major factors restraining the growth of this market.

“The consumables segment accounted for the largest market share in 2020.”
Based on products, the oxidative stress assay market is segmented into consumables, instruments, and software and services. Consumables is the largest and fastest-growing segment in 2020. This large share and high growth can be attributed the recurring requirement of consumables as compared to instruments which is the key factor driving the growth of this segment.

“The cardiovascular diseases segment will continue to dominate the oxidative stress assay market during the forecast period.”
Based on disease type, the oxidative stress assays market is segmented into cardiovascular diseases, diabetes, cancer, respiratory diseases, and other diseases. The cardiovascular diseases segment accounted for the largest share of this market in 2020, primarily due to the high and growing prevalence of cardiovascular diseases across the globe.

“The oxidative stress assay market in the Asia Pacific region is expected to witness the highest growth rate during the forecast period.”
Geographically, the oxidative stress assay market is segmented into North America, Europe, Asia Pacific, and Rest of the World. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period, primarily due to the reason that the Asia Pacific oxidative stress assays market offers significant growth opportunities for market players to expand their presence in this region. Emerging markets such as China and India are witnessing growth due to the large patient population and increasing healthcare expenditure. This has resulted in the increasing acceptance of advanced technologies, such as oxidative stress assays, in the Asia Pacific region.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 55%, Tier 2: 20%, and Tier 3: 25%
• By Designation: C-level: 35%, Director-level: 25%, and Others: 40%
• By Region: North America – 20%, Europe – 25%, APAC – 40%, Rest of the World– 15%

The prominent players in this market are Abcam, plc (UK), Enzo Biochem, Inc. (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), AMS Biotechnology (Europe), Ltd. (UK), BioVision, Inc. (US), Cell Biolabs, Inc. (US), Oxford Biomedical Research (US), Promega Corporation (US), Cayman Chemical (US), Eagle Biosciences, Inc. (US), Arbor Assays (US), Hycult Biotech (Netherlands), Callegari SRL (Italy), Kamiya Biomedical Company (US), MEGA TIP San.Tic.Ltd.Sti. (Turkey), ImmunoChemistry Technologies, LLC (US), Genox Corporation (US), and Toxys B.V. (Netherlands).

Research Coverage
• The report studies the oxidative stress assay market based on test type, technology, disease type, product, end user and region
• The report analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total oxidative stress assay market
• The report forecasts the revenue of market segments with respect to four major regions

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the oxidative stress assay offered by the key 20 players in the oxidative stress assay market. The report analyzes the oxidative stress assay market by test type, technology, disease type, product, end user and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various oxidative stress assay, their adoption, and usage across key geographic regions.
• Market Diversification: Exhaustive information about new product launches & approvals, untapped geographies, recent developments, and investments in the oxidative stress assay market
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the oxidative stress assay market.

*** レポート目次(コンテンツ)***

1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.3 MARKETS COVERED 31
FIGURE 1 OXIDATIVE STRESS ASSAYS MARKET SEGMENTATION 31
1.3.1 YEARS CONSIDERED FOR THE STUDY 32
1.4 CURRENCY 32
1.5 LIMITATIONS 32
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 33
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 36
2.1.2.1 Key data from primary sources 37
2.1.3 KEY INDUSTRY INSIGHTS 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 38
2.2 MARKET SIZE ESTIMATION 38
2.2.1 BOTTOM-UP APPROACH 38
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 39
2.2.2 GROWTH FORECAST 39
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 40
FIGURE 5 DATA TRIANGULATION METHODOLOGY 40
2.4 ASSUMPTIONS FOR THE STUDY 41
3 EXECUTIVE SUMMARY 42
FIGURE 6 OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD MILLION) 42
FIGURE 7 OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2020 VS. 2025 (USD MILLION) 43
FIGURE 8 OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 43
FIGURE 9 OXIDATIVE STRESS ASSAYS MARKET, BY REGION,
2020 VS. 2025 (USD MILLION) 44

4 PREMIUM INSIGHTS 45
4.1 OXIDATIVE STRESS ASSAYS MARKET OVERVIEW 45
FIGURE 10 GROWING R&D EXPENDITURE IN PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRIES TO DRIVE MARKET GROWTH 45
4.2 NORTH AMERICA: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET (2020) 46
FIGURE 11 OXIDATIVE STRESS ASSAY KITS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET 46
4.3 OXIDATIVE STRESS ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
FIGURE 12 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
FIGURE 13 OXIDATIVE STRESS ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 48
5.2.1 DRIVERS 49
5.2.1.1 Rapid growth in the biopharmaceutical and biotechnology industries 49
5.2.1.2 Growing R&D expenditure in the pharmaceutical & biopharmaceutical industries 49
FIGURE 14 R&D SPENDING OF PHRMA MEMBER COMPANIES, 2005–2019 (USD BILLION) 50
5.2.1.3 Technological advancements such as high-content screening for drug discovery 50
5.2.1.4 Government funding for life science research 50
5.2.1.5 Emergence of label-free detection technologies 51
5.2.2 RESTRAINTS 51
5.2.2.1 High cost of instruments 51
5.2.2.2 Shortage of trained personnel for new and emerging technologies 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Emerging economies present significant growth opportunities 52
5.2.3.2 Applications of oxidative stress measurement in the cosmetic industry 52
5.3 PORTER’S FIVE FORCES ANALYSIS 53
TABLE 1 OXIDATIVE STRESS ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 53
5.3.1 THREAT OF NEW ENTRANTS 53
5.3.2 THREAT OF SUBSTITUTES 53
5.3.3 BARGAINING POWER OF SUPPLIERS 53
5.3.4 BARGAINING POWER OF BUYERS 54
5.3.5 DEGREE OF COMPETITION 54
5.4 SUPPLY CHAIN ANALYSIS 54
FIGURE 15 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES 55
5.5 VALUE CHAIN ANALYSIS 56
FIGURE 16 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 56
5.6 ECOSYSTEM ANALYSIS OF THE OXIDATIVE STRESS ASSAYS MARKET 57
FIGURE 17 ECOSYSTEM ANALYSIS 57
5.7 COVID-19 IMPACT ANALYSIS 57
6 OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE 58
6.1 INTRODUCTION 59
TABLE 2 OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 59
6.2 CONSUMABLES 59
TABLE 3 OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 59
TABLE 4 OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY REGION,
2018–2025 (USD MILLION) 60
6.2.1 KITS 60
6.2.1.1 Kits accounted for the largest share of the oxidative stress assays market 60
TABLE 5 OXIDATIVE STRESS ASSAY KITS MARKET, BY REGION,
2018–2025 (USD MILLION) 60
6.2.2 REAGENTS 61
6.2.2.1 Antibodies are the most widely used reagents in oxidative stress assays 61
TABLE 6 OXIDATIVE STRESS ASSAY REAGENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 61
6.3 INSTRUMENTS 61
6.3.1 INSTRUMENTS SEGMENT TO WITNESS LOWER GROWTH THAN THE CONSUMABLES SEGMENT 61
TABLE 7 OXIDATIVE STRESS ASSAY INSTRUMENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 62
6.4 SERVICES 62
6.4.1 SERVICES SEGMENT TO ACCOUNT FOR A LOW SHARE OF THE MARKET DURING THE FORECAST PERIOD 62
TABLE 8 OXIDATIVE STRESS ASSAY SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 62
7 OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY 63
7.1 INTRODUCTION 64
TABLE 9 OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 64
7.2 ELISA 64
7.2.1 ELISA SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 64
TABLE 10 OXIDATIVE STRESS ASSAYS MARKET FOR ELISA, BY REGION,
2018–2025 (USD MILLION) 65
7.3 FLOW CYTOMETRY 65
7.3.1 FLOW CYTOMETRY IS USEFUL FOR THE MEASUREMENT OF CELLULAR OXIDATIVE STRESS 65
TABLE 11 OXIDATIVE STRESS ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2018–2025 (USD MILLION) 66
7.4 CHROMATOGRAPHY 66
7.4.1 GAS CHROMATOGRAPHY IS THE PREFERRED METHOD FOR THE ANALYSIS OF HNE 66
TABLE 12 OXIDATIVE STRESS ASSAYS MARKET FOR CHROMATOGRAPHY, BY REGION, 2018–2025 (USD MILLION) 67
7.5 MICROSCOPY 67
7.5.1 DIGITAL MICROSCOPES WITH ADVANCED FEATURES ARE USED TO EVALUATE OXIDATIVE STRESS 67
TABLE 13 OXIDATIVE STRESS ASSAYS MARKET FOR MICROSCOPY, BY REGION,
2018–2025 (USD MILLION) 67
7.6 HIGH-CONTENT SCREENING 68
7.6.1 HCS IS AN EMERGING TECHNOLOGY IN THE OXIDATIVE STRESS ASSAYS MARKET 68
TABLE 14 OXIDATIVE STRESS ASSAYS MARKET FOR HIGH-CONTENT SCREENING,
BY REGION, 2018–2025 (USD MILLION) 68
7.7 LABEL-FREE DETECTION 68
7.7.1 LABEL-FREE DETECTION SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 68
TABLE 15 OXIDATIVE STRESS ASSAYS MARKET FOR LABEL-FREE DETECTION,
BY REGION, 2018–2025 (USD MILLION) 69
8 OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE 70
8.1 INTRODUCTION 71
TABLE 16 OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 71
8.2 INDIRECT ASSAYS 71
TABLE 17 OXIDATIVE STRESS ASSAYS MARKET FOR INDIRECT ASSAYS, BY TYPE,
2018–2025 (USD MILLION) 71
TABLE 18 OXIDATIVE STRESS ASSAYS MARKET FOR INDIRECT ASSAYS, BY REGION, 2018–2025 (USD MILLION) 72
8.2.1 PROTEIN-BASED ASSAYS 72
8.2.1.1 Protein-based assays accounted for the largest share of the indirect assays market 72
TABLE 19 OXIDATIVE STRESS ASSAYS MARKET FOR PROTEIN-BASED ASSAYS,
BY REGION, 2018–2025 (USD MILLION) 73
8.2.2 LIPID-BASED ASSAYS 73
8.2.2.1 The most commonly used lipid peroxidation assays are MDA assays 73
TABLE 20 OXIDATIVE STRESS ASSAYS MARKET FOR LIPID-BASED ASSAYS, BY REGION, 2018–2025 (USD MILLION) 73
8.2.3 NUCLEIC ACID-BASED ASSAYS 74
8.2.3.1 Nucleic acid-based assays accounted for the lowest share of the indirect assays market 74
TABLE 21 OXIDATIVE STRESS ASSAYS MARKET FOR NUCLEIC ACID-BASED ASSAYS,
BY REGION, 2018–2025 (USD MILLION) 74
8.3 ANTIOXIDANT CAPACITY ASSAYS 74
TABLE 22 OXIDATIVE STRESS ASSAYS MARKET FOR ANTIOXIDANT CAPACITY ASSAYS, BY TYPE, 2018–2025 (USD MILLION) 75
TABLE 23 OXIDATIVE STRESS ASSAYS MARKET FOR ANTIOXIDANT CAPACITY ASSAYS, BY REGION, 2018–2025 (USD MILLION) 75
8.3.1 GLUTATHIONE ASSAYS 75
8.3.1.1 Glutathione assays accounted for the largest share of the antioxidant capacity assays market 75
TABLE 24 OXIDATIVE STRESS ASSAYS MARKET FOR GLUTATHIONE ASSAYS, BY REGION, 2018–2025 (USD MILLION) 76
8.3.2 ASCORBIC ACID ASSAYS 76
8.3.2.1 Ascorbic acid assay kits are based on FRASC chemistry 76
TABLE 25 OXIDATIVE STRESS ASSAYS MARKET FOR ASCORBIC ACID ASSAYS,
BY REGION, 2018–2025 (USD MILLION) 76
8.3.3 CELL-BASED EXOGENOUS ANTIOXIDANT ASSAYS 77
8.3.3.1 These assays are used for measuring the activity of an exogenous antioxidant compound within adherent cells 77
TABLE 26 OXIDATIVE STRESS ASSAYS MARKET FOR CELL-BASED EXOGENOUS ANTIOXIDANT ASSAYS, BY REGION, 2018–2025 (USD MILLION) 77
8.4 ENZYME-BASED ASSAYS 77
8.4.1 CATALASE ACTIVITY ASSAYS AND SOD ASSAYS ARE THE TWO TYPES OF ENZYME-BASED ASSAYS AVAILABLE IN THE MARKET 77
TABLE 27 OXIDATIVE STRESS ASSAYS MARKET FOR ENZYME-BASED ASSAYS,
BY REGION, 2018–2025 (USD MILLION) 78
8.5 REACTIVE OXYGEN SPECIES-BASED ASSAYS 78
8.5.1 ROS ASSAY KITS MEASURE THE ACTIVITY OF HYDROXYL, PEROXYL, AND OTHER REACTIVE OXYGEN SPECIES 78
TABLE 28 OXIDATIVE STRESS ASSAYS MARKET FOR REACTIVE OXYGEN SPECIES-BASED ASSAYS, BY REGION, 2018–2025 (USD MILLION) 79
9 OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE 80
9.1 INTRODUCTION 81
TABLE 29 OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 81
9.2 CARDIOVASCULAR DISEASES 81
9.2.1 HIGH PREVALENCE OF CARDIOVASCULAR DISEASES WILL DRIVE MARKET GROWTH 81
TABLE 30 OXIDATIVE STRESS ASSAYS MARKET FOR CARDIOVASCULAR DISEASES,
BY REGION, 2018–2025 (USD MILLION) 82
9.3 CANCER 82
9.3.1 RISING INCIDENCE OF CANCER TO DRIVE MARKET GROWTH 82
FIGURE 18 WORLDWIDE ESTIMATED NUMBER OF NEW CANCER CASES IN FEMALES
(ALL AGE GROUPS), 2020 82
FIGURE 19 WORLDWIDE ESTIMATED NUMBER OF NEW CANCER CASES IN MALES
(ALL AGE GROUPS), 2020 83
TABLE 31 OXIDATIVE STRESS ASSAYS MARKET FOR CANCER, BY REGION,
2018–2025 (USD MILLION) 83
9.4 DIABETES 84
9.4.1 HIGH AND GROWING PREVALENCE OF DIABETES TO BOOST MARKET GROWTH 84
TABLE 32 OXIDATIVE STRESS ASSAYS MARKET FOR DIABETES, BY REGION,
2018–2025 (USD MILLION) 84
9.5 RESPIRATORY DISEASES 84
9.5.1 RISING PREVALENCE OF COPD TO BOOST MARKET GROWTH 84
TABLE 33 OXIDATIVE STRESS ASSAYS MARKET FOR RESPIRATORY DISEASES,
BY REGION, 2018–2025 (USD MILLION) 85
9.6 OTHER DISEASES 85
TABLE 34 OXIDATIVE STRESS ASSAYS MARKET FOR OTHER DISEASES, BY REGION, 2018–2025 (USD MILLION) 86
10 OXIDATIVE STRESS ASSAYS MARKET, BY END USER 87
10.1 INTRODUCTION 88
TABLE 35 OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 88
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 88
10.2.1 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF OXIDATIVE STRESS ASSAYS 88
TABLE 36 OXIDATIVE STRESS ASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION) 89
10.3 ACADEMIC RESEARCH INSTITUTES 89
10.3.1 STRENGTHENING OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH 89
FIGURE 20 PUBLIC-SECTOR RESEARCH FUNDING IS DRIVING THE GROWTH OF THE ACADEMIC RESEARCH INSTITUTES SEGMENT (2018–2020) 89
TABLE 37 OXIDATIVE STRESS ASSAYS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 90
10.4 CLINICAL LABORATORIES 90
10.4.1 OXIDATIVE STRESS ASSAYS ARE USED IN PRECLINICAL BIOLOGICAL TESTING 90
TABLE 38 OXIDATIVE STRESS ASSAYS MARKET FOR CLINICAL LABORATORIES,
BY REGION, 2018–2025 (USD MILLION) 90
10.5 CONTRACT RESEARCH ORGANIZATIONS 91
10.5.1 OUTSOURCING OF PHARMACEUTICAL R&D ACTIVITIES TO DRIVE MARKET GROWTH 91
TABLE 39 OXIDATIVE STRESS ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION) 91
10.6 COSMETIC INDUSTRY 91
10.6.1 ADOPTION OF OXIDATIVE STRESS ASSAYS IS EXPECTED TO INCREASE IN THE COSMETIC INDUSTRY 91
TABLE 40 OXIDATIVE STRESS ASSAYS MARKET FOR COSMETIC INDUSTRY, BY REGION, 2018–2025 (USD MILLION) 92
11 OXIDATIVE STRESS ASSAYS MARKET, BY REGION 93
11.1 INTRODUCTION 94
TABLE 41 OXIDATIVE STRESS ASSAYS MARKET, BY REGION,
2018–2025 (USD MILLION) 94
11.2 NORTH AMERICA 95
FIGURE 21 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET SNAPSHOT 95
TABLE 42 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 96
TABLE 43 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 96
TABLE 44 NORTH AMERICA: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 96
TABLE 45 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 97
TABLE 46 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 97
TABLE 47 NORTH AMERICA: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 97
TABLE 48 NORTH AMERICA: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 49 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION) 98
TABLE 50 NORTH AMERICA: OXIDATIVE STRESS ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION) 98
11.2.1 US 99
11.2.1.1 The US is the largest market for oxidative stress assays 99
TABLE 51 US: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 99
TABLE 52 US: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 100
TABLE 53 US: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 100
TABLE 54 US: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 100
TABLE 55 US: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 101
TABLE 56 US: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 101
TABLE 57 US: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 101
TABLE 58 US: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 102
11.2.2 CANADA 102
11.2.2.1 Increasing biopharmaceutical industry to drive market growth in Canada 102
TABLE 59 CANADA: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 102
TABLE 60 CANADA: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 103
TABLE 61 CANADA: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 103
TABLE 62 CANADA: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 103
TABLE 63 CANADA: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 104
TABLE 64 CANADA: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 104
TABLE 65 CANADA: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 104
TABLE 66 CANADA: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 105
11.3 EUROPE 105
TABLE 67 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 105
TABLE 68 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 105
TABLE 69 EUROPE: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 106
TABLE 70 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 106
TABLE 71 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 106
TABLE 72 EUROPE: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 107
TABLE 73 EUROPE: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 107
TABLE 74 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 107
TABLE 75 EUROPE: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 108
11.3.1 GERMANY 108
11.3.1.1 Germany is the largest market for oxidative stress assay products in Europe 108
TABLE 76 GERMANY: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 108
TABLE 77 GERMANY: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 78 GERMANY: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 109
TABLE 79 GERMANY: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 109
TABLE 80 GERMANY: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 110
TABLE 81 GERMANY: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 110
TABLE 82 GERMANY: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 110
TABLE 83 GERMANY: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 111
11.3.2 UK 111
11.3.2.1 High burden of CVD in the UK to drive the adoption of oxidative stress assay products 111
TABLE 84 UK: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 111
TABLE 85 UK: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 86 UK: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 112
TABLE 87 UK: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 112
TABLE 88 UK: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 113
TABLE 89 UK: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 113
TABLE 90 UK: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 113
TABLE 91 UK: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 114
11.3.3 FRANCE 114
11.3.3.1 Rising prevalence of COPD in France to drive market growth 114
TABLE 92 FRANCE: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 114
TABLE 93 FRANCE: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 115
TABLE 94 FRANCE: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 115
TABLE 95 FRANCE: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 115
TABLE 96 FRANCE: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 116
TABLE 97 FRANCE: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
TABLE 98 FRANCE: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 116
TABLE 99 FRANCE: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 117
11.3.4 ITALY 117
11.3.4.1 Sluggish growth in the Italian healthcare sector to hamper market growth 117
TABLE 100 ITALY: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 117
TABLE 101 ITALY: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 118
TABLE 102 ITALY: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 118
TABLE 103 ITALY: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 118
TABLE 104 ITALY: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 119
TABLE 105 ITALY: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 119
TABLE 106 ITALY: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 119
TABLE 107 ITALY: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 120
11.3.5 SPAIN 120
11.3.5.1 Rising prevalence of chronic diseases to support market growth 120
TABLE 108 SPAIN: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 120
TABLE 109 SPAIN: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 110 SPAIN: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 121
TABLE 111 SPAIN: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 121
TABLE 112 SPAIN: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 113 SPAIN: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 114 SPAIN: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 122
TABLE 115 SPAIN: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 123
11.3.6 REST OF EUROPE 123
TABLE 116 ROE: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 123
TABLE 117 ROE: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 118 ROE: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 124
TABLE 119 ROE: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 124
TABLE 120 ROE: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 125
TABLE 121 ROE: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 122 ROE: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 125
TABLE 123 ROE: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 126
11.4 ASIA PACIFIC 126
TABLE 124 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 126
TABLE 125 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 126
TABLE 126 ASIA PACIFIC: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 127 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 127
TABLE 128 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 127
TABLE 129 ASIA PACIFIC: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 128
TABLE 130 ASIA PACIFIC: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 128
TABLE 131 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE, 2018–2025 (USD MILLION) 128
TABLE 132 ASIA PACIFIC: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 129
11.4.1 JAPAN 129
11.4.1.1 Japan is the largest market for oxidative stress assays in the APAC 129
TABLE 133 JAPAN: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 129
TABLE 134 JAPAN: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 135 JAPAN: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 130
TABLE 136 JAPAN: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 130
TABLE 137 JAPAN: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 138 JAPAN: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 139 JAPAN: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 131
TABLE 140 JAPAN: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 132
11.4.2 CHINA 132
11.4.2.1 China is the fastest-growing market for oxidative stress assays 132
TABLE 141 CHINA: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 132
TABLE 142 CHINA: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 133
TABLE 143 CHINA: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 133
TABLE 144 CHINA: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 133
TABLE 145 CHINA: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 134
TABLE 146 CHINA: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 147 CHINA: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 134
TABLE 148 CHINA: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 135
11.4.3 INDIA 135
11.4.3.1 Rising prevalence of chronic diseases to propel market growth 135
TABLE 149 INDIA: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 135
TABLE 150 INDIA: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 151 INDIA: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 136
TABLE 152 INDIA: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 136
TABLE 153 INDIA: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 137
TABLE 154 INDIA: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 137
TABLE 155 INDIA: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 137
TABLE 156 INDIA: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 138
11.4.4 REST OF ASIA PACIFIC 138
TABLE 157 ROAPAC: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 138
TABLE 158 ROAPAC: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 139
TABLE 159 ROAPAC: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 139
TABLE 160 ROAPAC: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 139
TABLE 161 ROAPAC: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 140
TABLE 162 ROAPAC: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 140
TABLE 163 ROAPAC: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 140
TABLE 164 ROAPAC: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 141
11.5 REST OF THE WORLD 141
TABLE 165 ROW: OXIDATIVE STRESS ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 141
TABLE 166 ROW: OXIDATIVE STRESS ASSAY CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 141
TABLE 167 ROW: OXIDATIVE STRESS ASSAYS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 142
TABLE 168 ROW: OXIDATIVE STRESS ASSAYS MARKET, BY TEST TYPE,
2018–2025 (USD MILLION) 142
TABLE 169 ROW: OXIDATIVE STRESS ANTIOXIDANT CAPACITY ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION) 142
TABLE 170 ROW: OXIDATIVE STRESS INDIRECT ASSAYS MARKET, BY TYPE,
2018–2025 (USD MILLION) 143
TABLE 171 ROW: OXIDATIVE STRESS ASSAYS MARKET, BY DISEASE TYPE,
2018–2025 (USD MILLION) 143
TABLE 172 ROW: OXIDATIVE STRESS ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 143
12 COMPETITIVE LANDSCAPE 144
12.1 OVERVIEW 144
FIGURE 22 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN JANUARY 2017 AND DECEMBER 2020 144
FIGURE 23 MARKET EVOLUTION FRAMEWORK 145
12.2 MARKET SHARE ANALYSIS 146
12.2.1 INTRODUCTION 146
FIGURE 24 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 146
12.3 COMPANY EVALUATION MATRIX 147
12.3.1 STARS 147
12.3.2 EMERGING LEADERS 147
12.3.3 PERVASIVE PLAYERS 147
12.3.4 PARTICIPANTS 148
FIGURE 25 OXIDATIVE STRESS ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 148
12.4 COMPETITIVE SITUATIONS AND TRENDS 149
12.4.1 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2020) 149
TABLE 173 OXIDATIVE STRESS ASSAYS MARKET: KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2020) 149
12.4.2 KEY PRODUCT LAUNCHES (2017–2020) 149
TABLE 174 OXIDATIVE STRESS ASSAYS MARKET: KEY PRODUCT LAUNCHES
(2017–2020) 149
12.4.3 KEY ACQUISITIONS (2017–2020) 149
TABLE 175 OXIDATIVE STRESS ASSAYS MARKET: KEY ACQUISITIONS (2017–2020) 149
12.4.4 KEY EXPANSIONS (2017–2020) 150
TABLE 176 OXIDATIVE STRESS ASSAYS MARKET: KEY EXPANSIONS (2017–2020) 150
13 COMPANY PROFILES 151
13.1 MAJOR PLAYERS 151
(Business overview, Products offered, Recent developments, MNM view)*
13.1.1 ABCAM PLC 151
TABLE 177 ABCAM PLC: BUSINESS OVERVIEW 151
FIGURE 26 ABCAM PLC: COMPANY SNAPSHOT (2019) 152
TABLE 178 ABCAM PLC: PRODUCTS OFFERED 152
13.1.2 ENZO BIOCHEM, INC. 154
TABLE 179 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW 154
FIGURE 27 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2019) 154
TABLE 180 ENZO BIOCHEM, INC.: PRODUCTS OFFERED 155
13.1.3 MERCK KGAA 156
TABLE 181 MERCK KGAA: BUSINESS OVERVIEW 156
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2019) 156
TABLE 182 MERCK KGAA: PRODUCTS OFFERED 157
13.1.4 QIAGEN N.V. 158
TABLE 183 QIAGEN N.V.: BUSINESS OVERVIEW 158
FIGURE 29 QIAGEN N.V.: COMPANY SNAPSHOT (2019) 158
TABLE 184 QIAGEN N.V.: PRODUCTS OFFERED 159
13.1.5 THERMO FISHER SCIENTIFIC, INC. 160
TABLE 185 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 160
FIGURE 30 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019) 160
TABLE 186 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED 161
13.1.6 AMS BIOTECHNOLOGY (EUROPE) LTD. 162
TABLE 187 AMS BIOTECHNOLOGY (EUROPE), LTD.: BUSINESS OVERVIEW 162
TABLE 188 AMS BIOTECHNOLOGY (EUROPE) LTD.: PRODUCTS OFFERED 162
13.1.7 BIOVISION, INC. 163
TABLE 189 BIOVISION, INC.: BUSINESS OVERVIEW 163
TABLE 190 BIOVISION, INC.: PRODUCTS OFFERED 163
13.1.8 CELL BIOLABS, INC. 165
TABLE 191 CELL BIOLABS, INC.: BUSINESS OVERVIEW 165
TABLE 192 CELL BIOLABS, INC.: PRODUCTS OFFERED 165
13.1.9 OXFORD BIOMEDICAL RESEARCH 167
TABLE 193 OXFORD BIOMEDICAL RESEARCH: BUSINESS OVERVIEW 167
TABLE 194 OXFORD BIOMEDICAL RESEARCH: PRODUCTS OFFERED 167
13.1.10 CAYMAN CHEMICAL 169
TABLE 195 CAYMAN CHEMICAL: BUSINESS OVERVIEW 169
TABLE 196 CAYMAN CHEMICAL: PRODUCTS OFFERED 169
13.2 OTHER PLAYERS 171
13.2.1 EAGLE BIOSCIENCES, INC. 171
TABLE 197 EAGLE BIOSCIENCES, INC.: BUSINESS OVERVIEW 171
TABLE 198 EAGLE BIOSCIENCES, INC.: PRODUCTS OFFERED 171
13.2.2 ARBOR ASSAYS 173
TABLE 199 ARBOR ASSAYS.: BUSINESS OVERVIEW 173
TABLE 200 ARBOR ASSAYS: PRODUCTS OFFERED 173
13.2.3 HYCULT BIOTECH 175
TABLE 201 HYCULT BIOTECH: BUSINESS OVERVIEW 175
TABLE 202 HYCULT BIOTECH: PRODUCTS OFFERED 175
13.2.4 KAMIYA BIOMEDICAL COMPANY 177
TABLE 203 KAMIYA BIOMEDICAL COMPANY: BUSINESS OVERVIEW 177
TABLE 204 KAMIYA BIOMEDICAL COMPANY: PRODUCTS OFFERED 177
13.2.5 MEGA TIP SAN.TIC.LTD.STI. 178
TABLE 205 MEGA TIP SAN.TIC.LTD.STI.: BUSINESS OVERVIEW 178
TABLE 206 MEGA TIP SAN.TIC.LTD.STI.: PRODUCTS OFFERED 178
13.2.6 PROMEGA CORPORATION 179
13.2.7 CALLEGARI SRL 179
13.2.8 IMMUNOCHEMISTRY TECHNOLOGIES, LLC 180
13.2.9 GENOX CORPORATION 181
13.2.10 TOXYS B.V. 181
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
14 APPENDIX 182
14.1 DISCUSSION GUIDE 182
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 186
14.3 AVAILABLE CUSTOMIZATIONS 188
14.4 RELATED REPORTS 188
14.5 AUTHOR DETAILS 189



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(BT3416 )"世界の酸化ストレスアッセイ市場(~2025年):製品別(消耗品、機器、キット、サービス)、テストタイプ別(間接、核酸、グルタチオン、ROS)、技術別(ELISA、クロマトグラフィー)、疾患別(CVD、腫瘍)、エンドユーザー別(製薬、バイオテクノロジー)" (英文:Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, nucleic acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End Users (Pharma & Biotech) - Global Forecasts to 2025)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。